tradingkey.logo
tradingkey.logo
Search

Tonix Pharmaceuticals Holding Corp

TNXP
Add to Watchlist
11.870USD
-0.410-3.34%
Close 09-11 16:00ET
198.99MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-3.34%

5 Days

-9.67%

1 Month

-3.81%

6 Months

-15.09%

Year to Date

-24.01%

1 Year

-61.97%

Key Figures

12.440Open
12.615High
34.51KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.20%Turnover Ratio
12.280Prev. Close
11.660Low
409.74KTurnover
LossP/E Static
0.90P/B
0.00%Div Yield TTM
-65.39%ROA
29.19052wk High
50.37Volume Ratio
-130.04MNet Profit
16.79MShares
-14.6644EPS TTM
1.69Beta
-72.33%ROE
9.40052wk Low
5.95%Amplitude
88.83%Gross Margin
198.99MMarket Cap
3.36Reward/Risk
4.46%Risk Rate
More news coming soon, stay tuned...

Tonix Pharmaceuticals Holding Corp's Score

-0.20vs previous score
Forecast8.50
Financial Health8.35
Technical3.84
Valuation Dimensions7.56
Institutional Confidence3.00
Risk Assessment4.57

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
42.400Target Price
+230.48%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy11100000
Buy33332222
Hold00000000
Sell00000000
Strong Sell00000000

Tonix Pharmaceuticals Holding Corp Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-2.44/-2.70
Revenue / Forecast
13.54M/7.72M

Tonix Pharmaceuticals Holding Corp Profile

SectorPharmaceuticals
Ticker SymbolTNXP
Number of employees81
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.6.31%
Point72 Asset Management, L.P.3.89%
Vanguard Capital Management, LLC3.25%
Geode Capital Management, L.L.C.2.13%
Shareholder TypesProportion
Investment Advisor14.18%
Investment Advisor/Hedge Fund6.39%
Hedge Fund6.14%
Research Firm0.95%

FAQs

What is the current price of Tonix Pharmaceuticals Holding Corp (TNXP)?

The current price of Tonix Pharmaceuticals Holding Corp (TNXP) is 11.87.

What is the symbol of Tonix Pharmaceuticals Holding Corp?

The ticker symbol of Tonix Pharmaceuticals Holding Corp is TNXP.

What is the 52-week high of Tonix Pharmaceuticals Holding Corp?

The 52-week high of Tonix Pharmaceuticals Holding Corp is 29.19.

What is the 52-week low of Tonix Pharmaceuticals Holding Corp?

The 52-week low of Tonix Pharmaceuticals Holding Corp is 9.40.

What is the market capitalization of Tonix Pharmaceuticals Holding Corp?

The market capitalization of Tonix Pharmaceuticals Holding Corp is 198.99M.

Is Tonix Pharmaceuticals Holding Corp (TNXP) currently rated as Buy, Hold, or Sell?

According to analysts, Tonix Pharmaceuticals Holding Corp (TNXP) has an overall rating of Buy, with a price target of 42.40.

What is the Earnings Per Share (EPS TTM) of Tonix Pharmaceuticals Holding Corp (TNXP)?

The Earnings Per Share (EPS TTM) of Tonix Pharmaceuticals Holding Corp (TNXP) is -14.66.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.